BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 25267705)

  • 1. Quantitative susceptibility mapping: current status and future directions.
    Haacke EM; Liu S; Buch S; Zheng W; Wu D; Ye Y
    Magn Reson Imaging; 2015 Jan; 33(1):1-25. PubMed ID: 25267705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of magnetic field inhomogeneity effects for fast quantitative susceptibility mapping.
    Ngo GC; Bilgic B; Gagoski BA; Sutton BP
    Magn Reson Med; 2019 Mar; 81(3):1645-1658. PubMed ID: 30387905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility map-weighted imaging (SMWI) for neuroimaging.
    Gho SM; Liu C; Li W; Jang U; Kim EY; Hwang D; Kim DH
    Magn Reson Med; 2014 Aug; 72(2):337-46. PubMed ID: 24006248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Susceptibility Mapping: Concepts and Applications.
    Reichenbach JR; Schweser F; Serres B; Deistung A
    Clin Neuroradiol; 2015 Oct; 25 Suppl 2():225-30. PubMed ID: 26198880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?
    Schweser F; Deistung A; Lehr BW; Reichenbach JR
    Neuroimage; 2011 Feb; 54(4):2789-807. PubMed ID: 21040794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength.
    Deistung A; Schäfer A; Schweser F; Biedermann U; Turner R; Reichenbach JR
    Neuroimage; 2013 Jan; 65():299-314. PubMed ID: 23036448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.
    Barbosa JH; Santos AC; Tumas V; Liu M; Zheng W; Haacke EM; Salmon CE
    Magn Reson Imaging; 2015 Jun; 33(5):559-65. PubMed ID: 25721997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating hyperoxic effects in the rat brain using quantitative susceptibility mapping based on MRI phase.
    Hsieh MC; Kuo LW; Huang YA; Chen JH
    Magn Reson Med; 2017 Feb; 77(2):592-602. PubMed ID: 26834053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward online reconstruction of quantitative susceptibility maps: superfast dipole inversion.
    Schweser F; Deistung A; Sommer K; Reichenbach JR
    Magn Reson Med; 2013 Jun; 69(6):1582-94. PubMed ID: 22791625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility phase imaging with comparison to R2 mapping of iron-rich deep grey matter.
    Walsh AJ; Wilman AH
    Neuroimage; 2011 Jul; 57(2):452-61. PubMed ID: 21513807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.
    Eskreis-Winkler S; Zhou D; Liu T; Gupta A; Gauthier SA; Wang Y; Spincemaille P
    Magn Reson Imaging; 2017 Jan; 35():154-159. PubMed ID: 27587225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super-resolution T
    Van Steenkiste G; Poot DHJ; Jeurissen B; den Dekker AJ; Vanhevel F; Parizel PM; Sijbers J
    Magn Reson Med; 2017 May; 77(5):1818-1830. PubMed ID: 27367848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA).
    Hanspach J; Dwyer MG; Bergsland NP; Feng X; Hagemeier J; Bertolino N; Polak P; Reichenbach JR; Zivadinov R; Schweser F
    J Magn Reson Imaging; 2017 Nov; 46(5):1474-1484. PubMed ID: 28263417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter reproducibility of quantitative susceptibility mapping in a gadolinium phantom using MEDI+0 automatic zero referencing.
    Deh K; Kawaji K; Bulk M; Van Der Weerd L; Lind E; Spincemaille P; McCabe Gillen K; Van Auderkerke J; Wang Y; Nguyen TD
    Magn Reson Med; 2019 Feb; 81(2):1229-1236. PubMed ID: 30284727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for estimating and removing streaking artifacts in quantitative susceptibility mapping.
    Li W; Wang N; Yu F; Han H; Cao W; Romero R; Tantiwongkosi B; Duong TQ; Liu C
    Neuroimage; 2015 Mar; 108():111-22. PubMed ID: 25536496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods.
    Wharton S; Bowtell R
    Neuroimage; 2010 Nov; 53(2):515-25. PubMed ID: 20615474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative susceptibility map reconstruction using annihilating filter-based low-rank Hankel matrix approach.
    Ahn HS; Park SH; Ye JC
    Magn Reson Med; 2020 Mar; 83(3):858-871. PubMed ID: 31468595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echo-time dependency of quantitative susceptibility mapping reproducibility at different magnetic field strengths.
    Lancione M; Donatelli G; Cecchi P; Cosottini M; Tosetti M; Costagli M
    Neuroimage; 2019 Aug; 197():557-564. PubMed ID: 31075389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility-weighted imaging: current status and future directions.
    Liu S; Buch S; Chen Y; Choi HS; Dai Y; Habib C; Hu J; Jung JY; Luo Y; Utriainen D; Wang M; Wu D; Xia S; Haacke EM
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27192086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Susceptibility Mapping for Following Intracranial Hemorrhage.
    Sun H; Klahr AC; Kate M; Gioia LC; Emery DJ; Butcher KS; Wilman AH
    Radiology; 2018 Sep; 288(3):830-839. PubMed ID: 29916778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.